PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (PACAP) RECEPTOR (VPAC2) AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE

Details for Australian Patent Application No. 2003267990 (hide)

Owner BAYER PHARMACEUTICALS CORPORATION

Inventors Pan, Clark; Kelner, Drew N.; Whelan, James; Wang, Yu-chang John; Froland, Wayne A.; Wang, Wei; Dumas, Michael L.

Agent Davies Collison Cave

Pub. Number AU-A-2003267990

PCT Number PCT/US03/21761

PCT Pub. Number WO2004/006839

Priority 60/395,738 12.07.02 US

Filing date 11 July 2003

Wipo publication date 2 February 2004

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/395,738 12.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003267990

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267991-N-hydroxyamide derivatives possessing antibacterial activity

2003267989-PATHOGEN REDUCTION USING CHLORAMINES